Metronidazole Injection shortage
Current 4 presentations · 3 manufacturers · first FDA posting 2022-01-13 · last update 2026-10-06
Manufacturers: Baxter Healthcare, Gland Pharma Limited, InfoRLife SA
Stated reasons (per FDA): Discontinuation of the manufacture of the drug; Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48) | Baxter Healthcare | Current Available |
— | Posted 01/13/2022 Updated 10/02/2026 | |
| Metronidazole In Plastic Container, Injection, 500 mg/100 mL (NDC 47335-993-01) | Gland Pharma Limited | Current Unavailable |
Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug | Posted 01/13/2022 Updated 07/22/2026 |
| Metronidazole in Flexible Container, Injection, 500 mg/100 mL (NDC 0409-0152-24) | InfoRLife SA | Current Limited Availability |
Other | Labeler: Hospira Inc. | Posted 01/13/2022 Updated 10/06/2026 |
| Metronidazole, Injection, 500 mg/100 mL (NDC 25021-131-82) | InfoRLife SA | Current Limited Availability |
Other | Estimated recovery: November 2026; Marketed by Sagent Pharmaceuticals | Posted 01/13/2022 Updated 10/06/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)